According to the 2014 NCCN guidelines for multi-gene testing, women with mutations in the non-BRCA genes, such as TP53, PTEN, CDH1, ATM, CHEK2, or PALB2 tumor suppressor genes and others also have an increased risk of breast and ovarian cancer (2, 6). Here, PALB2 is linked to ovarian cancer.